Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations’) read with Schedule III of Listing Regulations, Wockhardt has informed the Exchanges that the Credit Facilities Committee of the Board of Directors of the Company, at its meeting held on 28th May, 2021, allotted 5,000 Nos. of Rated, Unlisted, Secured Non-Convertible Debentures (‘NCDs’) of face value of Rs. 1,00,000 each for an aggregate value of Rs 50 crore (Series B Tranche I) to Centrum Credit Opportunities Trust on private placement basis on the terms and conditions as stipulated in the debenture trust deed dated 27th April 2021, as amended from time to time and other transaction documents, as amended from time to time.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1768.75 |
Dr. Reddys Lab | 1337.30 |
Cipla | 1448.00 |
Lupin | 2155.25 |
Zydus Lifesciences | 1000.80 |
View more.. |